Oriental Rise Faces Nasdaq Delisting After 30-Day Sub-$1 Violation, Plans Hearing
Oriental Rise Holdings received a Nasdaq determination on April 15 notifying that its shares will be delisted after closing below $1.00 for 30 consecutive business days and are ineligible for the 180-day cure period due to a 1-for-20 reverse split. The company plans to request a hearing by April 22 to stay the April 24 suspension and is evaluating strategies to regain compliance.
1. Nasdaq Delisting Determination
On April 15, Oriental Rise Holdings was notified by Nasdaq’s Listing Qualifications Department that its ordinary shares failed to maintain a minimum $1.00 closing bid for 30 consecutive business days, in violation of Rule 5550(a)(2). The company’s December 30, 2025, 1-for-20 reverse stock split rendered it ineligible for the standard 180-calendar day compliance period under Rule 5810(c)(3)(A).
2. Hearing Request and Suspension Timeline
Nasdaq advised that, without a hearing request by April 22, trading in Oriental Rise’s ordinary shares will be suspended at the opening on April 24 and a Form 25-NSE will be filed with the SEC to remove the shares from listing. The company intends to timely request a hearing before a Nasdaq Hearings Panel, which will stay both the suspension and delisting filing until a determination is made.
3. Compliance Restoration Plans
Oriental Rise is currently evaluating options and plans to present a detailed strategy to the Hearings Panel aimed at regaining compliance with Nasdaq’s continued listing requirements. There is no assurance the panel will grant continued listing status or that the company can meet the necessary listing standards.